title: Management of osteoporosis after spinal cord injury: what can be done? Point/counterpoint.
authors.affiliation: Center of Excellence for the Medical Consequences of Spinal Cord Injury, Department of, Veterans Affairs Rehabilitation Research and Development, Mount Sinai School of Medicine, New York, NY, USA.
authors.forename: William A
authors.initials: WA
authors.lastname: Bauman
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Schnitzer
authors.forename: David
authors.initials: D
authors.lastname: Chen
mesh_terms: D000328:Adult; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000150:complications / Q000534:rehabilitation / Q000628:therapy*; D013119:Spinal Cord Injuries / Q000150:complications* / Q000503:physiopathology / Q000534:rehabilitation; D014808:Vitamin D Deficiency / Q000150:complications
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates